Profile
| Metric | Value |
|---|---|
| Full Name | Albemarle Corporation |
| Ticker | NYSE: ALB |
| Exchange | NYSE |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Country | United States |
| IPO | |
| Indexes | |
| Website | albemarle.com |
| Employees | 8,300 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $161.57 | |
| Price, 1D Change | +2.16% | |
| Market Cap | $19B | |
| TTM Dividend Yield | 1.00% | |
| PE Ratio | - | |
| Beta | 1.67 | |
| Revenue | $5B | |
| Revenue, 1Y Change | -44.08% | |
| EPS | -$11.20 | |
| EPS, 1Y Change | -183.82% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.41 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$11.20 | |
| EPS Estimate | -$0.88 | |
| EPS Est. Change | +92.11% | |
| Revenue | $5.38B | |
| Revenue Estimate | $5.01B | |
| Revenue Est. Change | -6.79% | |
| Current Price | $161.57 | |
| Price Target | - | $125.00 |
| Price Tgt. Change | - | -22.63% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $21.53 | $13.36 | -37.94% | |
| -$1.85 | -$11.20 | -505.86% | |
| -$0.88 | N/A | +92.11% | |
| $1.08 | N/A | +109.66% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.39B | $9.62B | +2.41% | |
| $5.49B | $5.38B | -2.09% | |
| $5.01B | N/A | -6.79% | |
| $5.45B | N/A | +1.40% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +79.56% | |
| Price, 3Y | -27.10% | |
| Market Cap, 1Y | +79.77% | |
| Market Cap, 3Y | -26.77% | |
| Revenue, 1Y | -44.08% | |
| Revenue, 3Y | +61.59% | |
| EPS, 1Y | -183.82% | |
| EPS, 3Y | -1,155.34% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $161.57 | |
| SMA 200 | $84.63 | |
| SMA 200 vs Price | -47.62% | |
| SMA 50 | $123.86 | |
| SMA 50 vs Price | -23.34% | |
| Beta | 1.67 | |
| ATR | $6.48 | |
| 14-Day RSI | 76.31 | |
| 10-Day Volatility | 48.91% | |
| 1-Year Volatility | 61.95% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.41 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.00% | |
| Total Dividend | $1.61 | |
| Dividends Paid | $311.28M | |
| Payout Ratio | -27.41% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $5.38B | |
| EPS | -$11.20 | |
| Gross Profit | $60.24M | |
| Gross Margin | 1.12% | |
| Operating Profit | -$630.71M | |
| Operating Margin | -110.61% | |
| Net Income | -$1.14B | |
| Net Margin | -21.12% | |
| EBITDA | -$39.77M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.37 | |
| Current Ratio | 1.95 | |
| Quick Ratio | 1.19 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 2.58 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 3.84 | |
| PB Ratio | 2.45 | |
| EV/EBITDA | 30.42 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $7.73B | |
| Cash & Equivalents | $1.19B | |
| Total Assets | $16.61B | |
| Current Assets | $3.84B | |
| Total Liabilities | $6.41B | |
| Current Liabilities | $1.97B | |
| Total Debt | $3.65B | |
| Short Term Debt | $430.65M | |
| Accounts Payable | $943.89M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $6.56B | |
| Operating Expenses | $690.95M | |
| Cost Of Goods Sold | $5.32B | |
| SG&A | $0.00 | |
| D&A | $588.64M | |
| Interest Expense | $0.00 | |
| Income Tax | $87.09M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $702.07M | |
| CFI | -$1.57B | |
| CFF | $1.24B | |
| Capex | $1.69B | |
| Free Cash Flow | -$983.72M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Mizuho | → | |
| Citigroup | → | |
| UBS | → | |
| Deutsche Bank | → | |
| Baird | → | |
| BMO Capital | → | |
| UBS | → | |
| Mizuho | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with ALB
Data Sources & References
- ALB Official Website www.albemarle.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/915913/000091591325000162/0000915913-25-000162-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/915913/000091591325000026/0000915913-25-000026-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ALB Profile on Yahoo Finance finance.yahoo.com/quote/ALB
- ALB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alb
FAQ
What is the ticker symbol for Albemarle Corporation?
The ticker symbol for Albemarle Corporation is NYSE:ALB
Does Albemarle Corporation pay dividends?
Yes, Albemarle Corporation pays dividends. The last payment was $0.41, with an ex-dividend date on December 12, 2025
What sector is Albemarle Corporation in?
Albemarle Corporation is in the Basic Materials sector
What industry is Albemarle Corporation in?
Albemarle Corporation is in the Specialty Chemicals industry
What country is Albemarle Corporation based in?
Albemarle Corporation is headquartered in United States
When did Albemarle Corporation go public?
Albemarle Corporation initial public offering (IPO) was on February 22, 1994
Is Albemarle Corporation in the S&P 500?
Yes, Albemarle Corporation is included in the S&P 500 index
Is Albemarle Corporation in the NASDAQ 100?
No, Albemarle Corporation is not included in the NASDAQ 100 index
Is Albemarle Corporation in the Dow Jones?
No, Albemarle Corporation is not included in the Dow Jones index
When was Albemarle Corporation last earnings report?
Albemarle Corporation's most recent earnings report was on November 5, 2025
When does Albemarle Corporation report earnings?
The next expected earnings date for Albemarle Corporation is February 11, 2026
